Delivery Order SPE2DR25D7005-SPE2DR26F3ERF
Award Date 1/13/26
Potential Completion Date 1/14/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $1,201.70, represents a small-value pharmaceutical transaction typical of the company's regular medical supply operations for federal defense healthcare systems. The contract was awarded on a competitive, non-set-aside basis and is scheduled...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,248.87 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on January 13, 2026, with completion scheduled for January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $12,608.31 and an ultimate completion date of January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract valued at $5,891.99, with an ultimate completion date of January 13, 2026. This non-set-aside competitive award was issued on January 12, 2026, with performance taking place at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $34,947.77 delivery order to AmerisourceBergen Drug Corp (via parent company Cencora, Inc.) on January 6, 2026, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a fully competitive, non-set-aside basis, demonstrating the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,201.71 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on January 12, 2026, with completion scheduled for January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare systems to manage nausea and vomiting, particularly in acute care...
- The Defense Logistics Agency awarded a delivery order valued at $15,998.79 to AmerisourceBergen Drug Corp for Ondansetron Orally Disintegrating Tablets 4mg (30-count) on January 9, 2026, with completion targeted for February 6, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a ceiling value of $11,315.12. This is a firm fixed price delivery order with an ultimate completion date of May 13, 2025, and represents a non-set-aside competitive procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...